Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study-Reference-Cited by-同舟云学术

Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study

Published:2018 Issue:5 Volume:94 Page:274-280
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Puvvada Soham D.,Guillén-Rodríguez José M.,Yan Jessica,Inclán Lora,Heard Kara,Rivera Xavier I.^ORCID,Anwer Faiz,Mahadevan Daruka,Schatz Jonathan H.,Persky Daniel O.

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference19 articles.

1. Press OW, et al: Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus ¹³¹iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016. J Clin Oncol 2013; 31: 314–320.

2. Hiddemann W, et al: Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 2005; 106: 3725–3732.

3. Marcus R, et al: Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma. J Clin Oncol 2008; 26: 4579–4586.

4. Rodriguez-Monge EJ, Cabanillas F: Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience. Hematol Oncol Clin North Am 1997; 11: 937–947.

5. Velasquez WS, et al: ESHAP – an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 1994; 12: 1169–1176.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for Lymphoma;The Oncologist;2024-01-11

2. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01

3. Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy;Haematologica;2023-08-31

4. Homomultimer Strategy for Improvement of Radiolabeled Peptides and Antibody Fragments in Tumor Targeting;Current Medicinal Chemistry;2022-09

5. Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2022-08